DHB4_HUMAN - dbPTM
DHB4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID DHB4_HUMAN
UniProt AC P51659
Protein Name Peroxisomal multifunctional enzyme type 2
Gene Name HSD17B4
Organism Homo sapiens (Human).
Sequence Length 736
Subcellular Localization Peroxisome.
Protein Description Bifunctional enzyme acting on the peroxisomal beta-oxidation pathway for fatty acids. Catalyzes the formation of 3-ketoacyl-CoA intermediates from both straight-chain and 2-methyl-branched-chain fatty acids..
Protein Sequence MGSPLRFDGRVVLVTGAGAGLGRAYALAFAERGALVVVNDLGGDFKGVGKGSLAADKVVEEIRRRGGKAVANYDSVEEGEKVVKTALDAFGRIDVVVNNAGILRDRSFARISDEDWDIIHRVHLRGSFQVTRAAWEHMKKQKYGRIIMTSSASGIYGNFGQANYSAAKLGLLGLANSLAIEGRKSNIHCNTIAPNAGSRMTQTVMPEDLVEALKPEYVAPLVLWLCHESCEENGGLFEVGAGWIGKLRWERTLGAIVRQKNHPMTPEAVKANWKKICDFENASKPQSIQESTGSIIEVLSKIDSEGGVSANHTSRATSTATSGFAGAIGQKLPPFSYAYTELEAIMYALGVGASIKDPKDLKFIYEGSSDFSCLPTFGVIIGQKSMMGGGLAEIPGLSINFAKVLHGEQYLELYKPLPRAGKLKCEAVVADVLDKGSGVVIIMDVYSYSEKELICHNQFSLFLVGSGGFGGKRTSDKVKVAVAIPNRPPDAVLTDTTSLNQAALYRLSGDWNPLHIDPNFASLAGFDKPILHGLCTFGFSARRVLQQFADNDVSRFKAIKARFAKPVYPGQTLQTEMWKEGNRIHFQTKVQETGDIVISNAYVDLAPTSGTSAKTPSEGGKLQSTFVFEEIGRRLKDIGPEVVKKVNAVFEWHITKGGNIGAKWTIDLKSGSGKVYQGPAKGAADTTIILSDEDFMEVVLGKLDPQKAFFSGRLKARGNIMLSQKLQMILKDYAKL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Phosphorylation-----MGSPLRFDGR
-----CCCCCEECCE
21.3323401153
15PhosphorylationDGRVVLVTGAGAGLG
CCEEEEEECCCCCHH
19.7020068231
462-HydroxyisobutyrylationNDLGGDFKGVGKGSL
ECCCCCCCCCCCCHH
58.38-
46AcetylationNDLGGDFKGVGKGSL
ECCCCCCCCCCCCHH
58.3823954790
46MalonylationNDLGGDFKGVGKGSL
ECCCCCCCCCCCCHH
58.3826320211
46SuccinylationNDLGGDFKGVGKGSL
ECCCCCCCCCCCCHH
58.38-
46SuccinylationNDLGGDFKGVGKGSL
ECCCCCCCCCCCCHH
58.3823954790
46UbiquitinationNDLGGDFKGVGKGSL
ECCCCCCCCCCCCHH
58.38-
502-HydroxyisobutyrylationGDFKGVGKGSLAADK
CCCCCCCCCHHHHHH
42.81-
50UbiquitinationGDFKGVGKGSLAADK
CCCCCCCCCHHHHHH
42.81-
52PhosphorylationFKGVGKGSLAADKVV
CCCCCCCHHHHHHHH
20.5124275569
572-HydroxyisobutyrylationKGSLAADKVVEEIRR
CCHHHHHHHHHHHHH
43.37-
57AcetylationKGSLAADKVVEEIRR
CCHHHHHHHHHHHHH
43.3723954790
57MalonylationKGSLAADKVVEEIRR
CCHHHHHHHHHHHHH
43.3726320211
57SuccinylationKGSLAADKVVEEIRR
CCHHHHHHHHHHHHH
43.37-
57SuccinylationKGSLAADKVVEEIRR
CCHHHHHHHHHHHHH
43.37-
57UbiquitinationKGSLAADKVVEEIRR
CCHHHHHHHHHHHHH
43.37-
68MalonylationEIRRRGGKAVANYDS
HHHHCCCEEECCCCC
42.3826320211
68SuccinylationEIRRRGGKAVANYDS
HHHHCCCEEECCCCC
42.38-
68SuccinylationEIRRRGGKAVANYDS
HHHHCCCEEECCCCC
42.38-
68UbiquitinationEIRRRGGKAVANYDS
HHHHCCCEEECCCCC
42.38-
73PhosphorylationGGKAVANYDSVEEGE
CCEEECCCCCHHHCH
10.3920071362
75PhosphorylationKAVANYDSVEEGEKV
EEECCCCCHHHCHHH
22.5225072903
812-HydroxyisobutyrylationDSVEEGEKVVKTALD
CCHHHCHHHHHHHHH
64.28-
81AcetylationDSVEEGEKVVKTALD
CCHHHCHHHHHHHHH
64.2823954790
81UbiquitinationDSVEEGEKVVKTALD
CCHHHCHHHHHHHHH
64.28-
84SuccinylationEEGEKVVKTALDAFG
HHCHHHHHHHHHHCC
30.94-
84SuccinylationEEGEKVVKTALDAFG
HHCHHHHHHHHHHCC
30.94-
112PhosphorylationDRSFARISDEDWDII
CCCEEECCCCCCCEE
29.42-
139AcetylationRAAWEHMKKQKYGRI
HHHHHHHHHHCCCEE
54.6923749302
139SuccinylationRAAWEHMKKQKYGRI
HHHHHHHHHHCCCEE
54.6923954790
143PhosphorylationEHMKKQKYGRIIMTS
HHHHHHCCCEEEEEC
14.78-
149PhosphorylationKYGRIIMTSSASGIY
CCCEEEEECCCCCCC
14.77-
150PhosphorylationYGRIIMTSSASGIYG
CCEEEEECCCCCCCC
13.41-
151PhosphorylationGRIIMTSSASGIYGN
CEEEEECCCCCCCCC
19.79-
153PhosphorylationIIMTSSASGIYGNFG
EEEECCCCCCCCCCC
27.8928348404
156PhosphorylationTSSASGIYGNFGQAN
ECCCCCCCCCCCCHH
15.00-
184UbiquitinationSLAIEGRKSNIHCNT
HHHHCCCCCCCCCCC
59.73-
185PhosphorylationLAIEGRKSNIHCNTI
HHHCCCCCCCCCCCC
39.39-
189GlutathionylationGRKSNIHCNTIAPNA
CCCCCCCCCCCCCCC
4.2122555962
265PhosphorylationRQKNHPMTPEAVKAN
HCCCCCCCHHHHHCC
23.5625159151
270AcetylationPMTPEAVKANWKKIC
CCCHHHHHCCHHHHC
42.9525953088
270UbiquitinationPMTPEAVKANWKKIC
CCCHHHHHCCHHHHC
42.95-
275SuccinylationAVKANWKKICDFENA
HHHCCHHHHCCCCCC
39.93-
275SuccinylationAVKANWKKICDFENA
HHHCCHHHHCCCCCC
39.93-
275UbiquitinationAVKANWKKICDFENA
HHHCCHHHHCCCCCC
39.93-
277GlutathionylationKANWKKICDFENASK
HCCHHHHCCCCCCCC
7.2322555962
283PhosphorylationICDFENASKPQSIQE
HCCCCCCCCCCHHHH
57.3530624053
287PhosphorylationENASKPQSIQESTGS
CCCCCCCHHHHHHCC
34.4628450419
290PhosphorylationSKPQSIQESTGSIIE
CCCCHHHHHHCCHHH
48.9027251275
291PhosphorylationKPQSIQESTGSIIEV
CCCHHHHHHCCHHHH
22.9928450419
292PhosphorylationPQSIQESTGSIIEVL
CCHHHHHHCCHHHHH
33.9128450419
294PhosphorylationSIQESTGSIIEVLSK
HHHHHHCCHHHHHHC
22.0825159151
300PhosphorylationGSIIEVLSKIDSEGG
CCHHHHHHCCCCCCC
32.5128450419
301AcetylationSIIEVLSKIDSEGGV
CHHHHHHCCCCCCCC
46.5026051181
304PhosphorylationEVLSKIDSEGGVSAN
HHHHCCCCCCCCCCC
41.4329255136
309PhosphorylationIDSEGGVSANHTSRA
CCCCCCCCCCCCCCC
26.9929255136
313PhosphorylationGGVSANHTSRATSTA
CCCCCCCCCCCCCCC
21.5129255136
314PhosphorylationGVSANHTSRATSTAT
CCCCCCCCCCCCCCC
16.6229255136
317PhosphorylationANHTSRATSTATSGF
CCCCCCCCCCCCCCC
26.0429255136
318PhosphorylationNHTSRATSTATSGFA
CCCCCCCCCCCCCCC
18.3029255136
319PhosphorylationHTSRATSTATSGFAG
CCCCCCCCCCCCCCH
29.6030266825
321PhosphorylationSRATSTATSGFAGAI
CCCCCCCCCCCCHHH
29.4830266825
322PhosphorylationRATSTATSGFAGAIG
CCCCCCCCCCCHHHC
29.4730266825
325PhosphorylationSTATSGFAGAIGQKL
CCCCCCCCHHHCCCC
15.2727251275
336PhosphorylationGQKLPPFSYAYTELE
CCCCCCCCCCHHHHH
18.0224275569
343PhosphorylationSYAYTELEAIMYALG
CCCHHHHHHHHHHHC
29.8927251275
347PhosphorylationTELEAIMYALGVGAS
HHHHHHHHHHCCCCC
7.8027251275
356SuccinylationLGVGASIKDPKDLKF
HCCCCCCCCHHHCCE
66.53-
356SuccinylationLGVGASIKDPKDLKF
HCCCCCCCCHHHCCE
66.53-
368PhosphorylationLKFIYEGSSDFSCLP
CCEEEECCCCCCCCC
18.1328348404
369PhosphorylationKFIYEGSSDFSCLPT
CEEEECCCCCCCCCC
54.2328348404
398PhosphorylationLAEIPGLSINFAKVL
CCCCCCEEEEEEEEC
22.7728348404
410PhosphorylationKVLHGEQYLELYKPL
EECCCHHHHHHHCCC
9.6129496907
414PhosphorylationGEQYLELYKPLPRAG
CHHHHHHHCCCCCCC
10.9429496907
415AcetylationEQYLELYKPLPRAGK
HHHHHHHCCCCCCCC
53.3423954790
415SuccinylationEQYLELYKPLPRAGK
HHHHHHHCCCCCCCC
53.3423954790
415UbiquitinationEQYLELYKPLPRAGK
HHHHHHHCCCCCCCC
53.34-
4242-HydroxyisobutyrylationLPRAGKLKCEAVVAD
CCCCCCCCCEEEEEE
33.25-
424AcetylationLPRAGKLKCEAVVAD
CCCCCCCCCEEEEEE
33.2526051181
424MalonylationLPRAGKLKCEAVVAD
CCCCCCCCCEEEEEE
33.2526320211
424SuccinylationLPRAGKLKCEAVVAD
CCCCCCCCCEEEEEE
33.25-
424SuccinylationLPRAGKLKCEAVVAD
CCCCCCCCCEEEEEE
33.25-
424UbiquitinationLPRAGKLKCEAVVAD
CCCCCCCCCEEEEEE
33.25-
446PhosphorylationVVIIMDVYSYSEKEL
EEEEEECCCCCCCEE
9.5322817900
448PhosphorylationIIMDVYSYSEKELIC
EEEECCCCCCCEEEE
11.8022817900
475PhosphorylationGFGGKRTSDKVKVAV
CCCCCCCCCCEEEEE
39.1928258704
496PhosphorylationPDAVLTDTTSLNQAA
CCCEEECCCCCCHHH
17.0428258704
497PhosphorylationDAVLTDTTSLNQAAL
CCEEECCCCCCHHHH
33.7428258704
565AcetylationAIKARFAKPVYPGQT
HHHHHCCCCCCCCCE
32.1019608861
565MalonylationAIKARFAKPVYPGQT
HHHHHCCCCCCCCCE
32.1026320211
565UbiquitinationAIKARFAKPVYPGQT
HHHHHCCCCCCCCCE
32.1019608861
579AcetylationTLQTEMWKEGNRIHF
EEEEEHHHCCCEEEE
55.2023954790
579MalonylationTLQTEMWKEGNRIHF
EEEEEHHHCCCEEEE
55.2032601280
579SuccinylationTLQTEMWKEGNRIHF
EEEEEHHHCCCEEEE
55.20-
579SuccinylationTLQTEMWKEGNRIHF
EEEEEHHHCCCEEEE
55.2023954790
599PhosphorylationETGDIVISNAYVDLA
ECCCEEEEEEEEEEC
12.4329978859
602PhosphorylationDIVISNAYVDLAPTS
CEEEEEEEEEECCCC
9.9630576142
608PhosphorylationAYVDLAPTSGTSAKT
EEEEECCCCCCCCCC
33.8928450419
609PhosphorylationYVDLAPTSGTSAKTP
EEEECCCCCCCCCCC
38.7328450419
611PhosphorylationDLAPTSGTSAKTPSE
EECCCCCCCCCCCCC
25.8628450419
612PhosphorylationLAPTSGTSAKTPSEG
ECCCCCCCCCCCCCC
31.1528450419
614AcetylationPTSGTSAKTPSEGGK
CCCCCCCCCCCCCCC
61.8125953088
615PhosphorylationTSGTSAKTPSEGGKL
CCCCCCCCCCCCCCE
31.5928450419
617PhosphorylationGTSAKTPSEGGKLQS
CCCCCCCCCCCCEEE
54.8527422710
621AcetylationKTPSEGGKLQSTFVF
CCCCCCCCEEEEEEH
54.9625953088
624PhosphorylationSEGGKLQSTFVFEEI
CCCCCEEEEEEHHHH
33.9626074081
625PhosphorylationEGGKLQSTFVFEEIG
CCCCEEEEEEHHHHH
15.7426074081
636AcetylationEEIGRRLKDIGPEVV
HHHHHHHHHHCHHHH
45.5523749302
636MalonylationEEIGRRLKDIGPEVV
HHHHHHHHHHCHHHH
45.5526320211
636UbiquitinationEEIGRRLKDIGPEVV
HHHHHHHHHHCHHHH
45.55-
637PhosphorylationEIGRRLKDIGPEVVK
HHHHHHHHHCHHHHH
56.5227251275
6442-HydroxyisobutyrylationDIGPEVVKKVNAVFE
HHCHHHHHHHCEEEE
57.06-
644AcetylationDIGPEVVKKVNAVFE
HHCHHHHHHHCEEEE
57.0623749302
644MalonylationDIGPEVVKKVNAVFE
HHCHHHHHHHCEEEE
57.0626320211
644SuccinylationDIGPEVVKKVNAVFE
HHCHHHHHHHCEEEE
57.0623954790
645MalonylationIGPEVVKKVNAVFEW
HCHHHHHHHCEEEEE
29.1632601280
655PhosphorylationAVFEWHITKGGNIGA
EEEEEEECCCCCCCC
15.68-
663AcetylationKGGNIGAKWTIDLKS
CCCCCCCEEEEECCC
39.3925953088
663SuccinylationKGGNIGAKWTIDLKS
CCCCCCCEEEEECCC
39.39-
663SuccinylationKGGNIGAKWTIDLKS
CCCCCCCEEEEECCC
39.39-
6692-HydroxyisobutyrylationAKWTIDLKSGSGKVY
CEEEEECCCCCCEEE
49.36-
669AcetylationAKWTIDLKSGSGKVY
CEEEEECCCCCCEEE
49.3619608861
674AcetylationDLKSGSGKVYQGPAK
ECCCCCCEEEECCCC
39.1925953088
674UbiquitinationDLKSGSGKVYQGPAK
ECCCCCCEEEECCCC
39.19-
676PhosphorylationKSGSGKVYQGPAKGA
CCCCCEEEECCCCCC
15.9629496907
7072-HydroxyisobutyrylationLGKLDPQKAFFSGRL
HCCCCHHHHHHCCCC
53.18-
707AcetylationLGKLDPQKAFFSGRL
HCCCCHHHHHHCCCC
53.1819608861
707MalonylationLGKLDPQKAFFSGRL
HCCCCHHHHHHCCCC
53.1826320211
707SuccinylationLGKLDPQKAFFSGRL
HCCCCHHHHHHCCCC
53.1827452117
707UbiquitinationLGKLDPQKAFFSGRL
HCCCCHHHHHHCCCC
53.1819608861
711PhosphorylationDPQKAFFSGRLKARG
CHHHHHHCCCCHHHC
19.2924719451
725AcetylationGNIMLSQKLQMILKD
CCCHHHHHHHHHHHH
36.9925953088
725SuccinylationGNIMLSQKLQMILKD
CCCHHHHHHHHHHHH
36.99-
725SuccinylationGNIMLSQKLQMILKD
CCCHHHHHHHHHHHH
36.99-
731AcetylationQKLQMILKDYAKL--
HHHHHHHHHHHCC--
37.4625953088
731MalonylationQKLQMILKDYAKL--
HHHHHHHHHHHCC--
37.4626320211
731SuccinylationQKLQMILKDYAKL--
HHHHHHHHHHHCC--
37.4623954790
731UbiquitinationQKLQMILKDYAKL--
HHHHHHHHHHHCC--
37.46-
733PhosphorylationLQMILKDYAKL----
HHHHHHHHHCC----
12.2124641631

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of DHB4_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of DHB4_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of DHB4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
THIK_HUMANACAA1physical
22939629
NLTP_HUMANSCP2physical
22939629
GRHPR_HUMANGRHPRphysical
22939629
SSBP_HUMANSSBP1physical
22939629
FIS1_HUMANFIS1physical
22939629
RACK1_HUMANGNB2L1physical
22939629
VAMP2_HUMANVAMP2physical
22939629
MK08_HUMANMAPK8physical
21988832

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
261515D-bifunctional protein deficiency (DBPD)
233400Perrault syndrome 1 (PRLTS1)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of DHB4_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-565; LYS-669 AND LYS-707,AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; THR-265; THR-292;SER-294; SER-304; SER-309; THR-317; SER-318 AND THR-608, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-265, AND MASSSPECTROMETRY.

TOP